These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10711134)

  • 21. Preventive techniques to limit glucocorticoid-induced side effects.
    Vittorio CC; Werth VP
    Adv Dermatol; 2000; 16():273-97; discussion 298. PubMed ID: 11094631
    [No Abstract]   [Full Text] [Related]  

  • 22. [Steroidal anti-inflammatory drugs].
    Ikekita A; Ueki M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():395-8. PubMed ID: 15658347
    [No Abstract]   [Full Text] [Related]  

  • 23. [Glucocorticoid-induced osteoporosis: recent findings].
    Angeli A; Osella G; Reimondo G; Terzolo M
    Ann Ital Med Int; 2000; 15(1):47-55. PubMed ID: 10842891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of medications and hormones used in pediatric endocrinology: adrenal.
    Frank GR; Speiser PW; Griffin KJ; Stratakis CA
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():134-45. PubMed ID: 16456492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The low-dose (1 microg) adrenocorticotropin stimulation test in kidney and kidney-pancreas transplant patients: a potential guideline for steroid withdrawal.
    Baz-Hecht M; Osher E; Yachnin T; Nakache R; Nakache G; Tordjman K; Stern N
    Clin Transplant; 2006; 20(1):72-7. PubMed ID: 16556157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical studies on glucocorticoid-induced osteoporosis].
    Tanaka I; Oshima H
    Nihon Rinsho Meneki Gakkai Kaishi; 2001 Aug; 24(4):142-151. PubMed ID: 16646164
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids.
    Muley SA; Kelkar P; Parry GJ
    Arch Neurol; 2008 Nov; 65(11):1460-4. PubMed ID: 19001164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glucocorticoid therapy in childhood].
    Butenandt O
    Fortschr Med; 1991 Aug; 109(23):455-9. PubMed ID: 1916578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring adverse reaction to steroid therapy in children.
    Seth A; Aggarwal A
    Indian Pediatr; 2004 Apr; 41(4):349-57. PubMed ID: 15123863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.
    Mortimer KJ; Tattersfield AE
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):523-39. PubMed ID: 16054541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimizing the side effects of glucocorticoid therapy.
    Baxter JD
    Adv Intern Med; 1990; 35():173-93. PubMed ID: 2405592
    [No Abstract]   [Full Text] [Related]  

  • 34. Corticosteroids: clinical pharmacology and therapeutic use.
    Swartz SL; Dluhy RG
    Drugs; 1978 Sep; 16(3):238-55. PubMed ID: 209958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica.
    Cutolo M; Foppiani L; Minuto F
    J Endocrinol Invest; 2002; 25(10 Suppl):19-23. PubMed ID: 12508908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Benefits and risks of glucocorticoid therapy for the treatment of rheumatoid arthritis and management of glucocorticoid-induced osteoporosis].
    Suzuki Y; Wakabayashi T; Saito E; Yamada C; Suwa A
    Clin Calcium; 2009 Mar; 19(3):404-15. PubMed ID: 19252251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [3/3 Steroidal or glucocorticoid anti-inflammatories].
    Grangeasse L; Limat S; Woronoff-Lemsi MC
    Soins; 2007 Apr; (714):59-61. PubMed ID: 17533931
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucocorticoid excess syndromes causing hypertension.
    Krakoff LR
    Cardiol Clin; 1988 Nov; 6(4):537-45. PubMed ID: 3067845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort].
    Rotenberger J; Köbberling J
    Med Klin (Munich); 1993 Jul; 88(7):432-7. PubMed ID: 8377721
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.